Weekly Recap

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

October 24, 2020

Neurology News Network for the week ending October 24, 2020.

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

October 17, 2020

Neurology News Network for the week ending October 17, 2020.

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

October 10, 2020

Neurology News Network for the week ending October 10, 2020.

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

October 03, 2020

Neurology News Network for the week ending October 2, 2020.

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

September 26, 2020

Neurology News Network for the week ending September 26, 2020.

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

September 19, 2020

Neurology News Network for the week ending September 19, 2020.

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

September 12, 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

September 05, 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

May 09, 2020

Neurology News Network for the week ending May 9, 2020.

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

May 02, 2020

Neurology News Network for the week ending May 2.